CTD advanced +1.8% on Monday, reducing its year-to-date decline to -13%; we bought the stock earlier this month following its poor result and subsequent downside rerating. We went long ~$16.50, believing the stock offers solid value for patient investors over the coming year or so through upside potential in the vast North American market, where CTD still has a market share of less than 1%. With legitimate plans to double its FY24 profits organically over the coming 5 years, we think CTD is still good buying at current levels.
- We like CTD from a risk/reward perspective ~$17, having recently bought the stock in our Active Growth Portfolio.